Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07368803RecruitingPhase 1/Phase 2
Personalized mRNA vaccine for bile duct cancer after surgery
This trial tests a personalized mRNA vaccine (iNeo-Vac-R01) made from your tumor's unique markers to help prevent cancer from coming back after surgery for bile duct or other digestive cancers. It may be an option if standard treatments have stopped working or caused side effects.
Hangzhou, ZhejiangAges 18–75 - NCT07369908Recruiting
Ear stimulation for anxiety and emotion control
This study tests whether a gentle, non-invasive electrical stimulation on the ear (called taVNS) can help lower anxiety and improve how you manage your emotions. It’s for healthy people who want to explore a potential new way to support emotional well-being.
Chengdu, SichuanAges 18–30 - NCT07364084Recruiting
Brain training for imagined social support
This trial uses real-time brain imaging (MRI) to train a part of your brain linked to imagining social support. It is for healthy volunteers who want to see if they can learn to control their brain activity.
Chengdu, SichuanAges 18–35 - NCT07370077Recruiting
Early screening for lung nodules with breath, blood, and CT scans
This trial uses a new, non-invasive way to screen for lung cancer by combining your breath, blood, and CT scan images. The goal is to figure out whether a nodule found on a CT scan is cancerous or not, which could help patients avoid unnecessary procedures.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07363967RecruitingPhase 1
Study of SWA1211 for advanced solid tumors
This trial tests a new oral drug, SWA1211, for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and works against the cancer.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07368127RecruitingPhase 1
Study of TPD3310 for advanced solid tumors
This trial tests an experimental drug called TPD3310 for people with advanced solid tumors (like lung, stomach, liver, or other cancers) that have worsened after standard treatments or cannot tolerate them. It aims to see if the drug is safe and works, especially for tumors with a specific marker called c-MET.
Beijing, Beijing MunicipalityAges 18–75 - NCT07362303Recruiting
Neuralert stroke monitor study for high-risk patients
This trial tests a device that monitors for stroke in adults who are at high risk after certain heart or blood vessel procedures. It could help detect a stroke early so you get treated faster.
Philadelphia, PennsylvaniaAges 22 years+ - NCT06712667Recruiting
Coffee and intense exercise: a caffeine metabolism study
This study looks at how coffee affects people who do intense exercise, and how their bodies process caffeine. It may help understand if coffee can improve exercise performance or recovery.
Shenzhen, GuangdongAges 18–40 - NCT07356531Recruiting
Thermosensitive Embolic Agent for Liver Cancer TACE
This trial tests a new heat-sensitive embolic agent used during TACE (a procedure that blocks blood flow to tumors and delivers chemotherapy directly to the liver) for primary liver cancer. It aims to see if the agent is safe and effective for patients who need TACE treatment.
Hefei, AnhuiAges 18–80 - NCT07360353Recruiting
Comparing different types of flexible ureteroscopes for kidney stones
This study compares different types of flexible ureteroscopes used to remove kidney stones. It looks at how well they work and their safety.
CairoAges 18–60 - NCT07356700Recruiting
Why do some people live past 95? A study in Hong Kong
This study looks at older adults who are at least 95 years old and of Han Chinese ethnicity to understand what helps people live a very long life. You'll be asked to provide a blood sample so scientists can study your genes and other health factors.
Hong KongAges 65 years+ - NCT07355972RecruitingEarly Phase 1
CT1195E cell therapy for progressive scleroderma
This trial tests a new cell therapy called CT1195E for people with refractory or progressive systemic sclerosis (scleroderma) that also affects the lungs. It aims to see if the treatment is safe and can help slow or stop the disease.
Wuhan, HubeiAges 18–60 - NCT07359703Recruiting
Aurora test for better embryo selection in ICSI
This study tests a new tool called the Aurora test, which looks at your eggs to help choose the best embryo for transfer. It may help improve success in your first few ICSI cycles.
GhentAges 18–40 - NCT06503237Recruiting
SWK002 for tough-to-treat rheumatoid arthritis
This trial tests a new treatment called SWK002 for people with rheumatoid arthritis that hasn't improved after trying multiple medications. It aims to see if SWK002 can help when other treatments have failed.
Changsha, HunanAges 18 years+ - NCT06851234Recruiting
Osteopathic treatment for head injuries in MMA fighters
This trial tests if osteopathic manipulative treatment (a gentle hands-on therapy) helps mixed martial artists recover from head injuries. Part 1 studies how head injuries happen during fights; Part 2 offers the treatment to fighters who get a head injury.
Greenvale, New YorkAges 18–50 - NCT06852911Recruiting
New FeNO device for asthma diagnosis
This study tests a new device that measures a lung marker called FeNO (fractional exhaled nitric oxide) to help diagnose asthma. It may be an option for adults with asthma who have not changed their medication recently and have no recent infections.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07348653RecruitingPhase 1
Study of MG2512 for advanced solid tumor patients
This trial tests a new drug called MG2512 for people with advanced solid tumors that have not responded to standard treatments or who cannot take standard therapy. The study aims to understand if MG2512 is safe and effective.
Beijing, Beijing MunicipalityAges 18–75 - NCT06856356Recruiting
Robot-assisted knee replacement surgery study
This study tests if robot-assisted total knee replacement surgery is safe and effective. It may help people who need knee replacement surgery by using advanced technology for more precise implant placement.
Hefei, AnhuiAges 18–80 - NCT07348471Recruiting
Gut bacteria transplant for ICU delirium
This study tests whether giving a transplant of healthy gut bacteria (called fecal microbiota transplantation) can help treat delirium in ICU patients. It may improve brain function by restoring gut health.
WuhanAges 18–80 - NCT07349966Enrolling by invitation
Biopsy effects on children born after genetic testing
This study compares children born after preimplantation genetic testing with a small biopsy of the embryo to those born without such testing. It aims to see if the biopsy affects a child's health and development during their first year of life.
Milan, MilanoAges Up to 5 years - NCT07347860RecruitingEarly Phase 1
Study of A-319 for active rheumatoid arthritis
This trial tests a new drug called A-319 for people with active rheumatoid arthritis (RA) that hasn't improved enough after trying other treatments. The goal is to see if A-319 can reduce joint pain, swelling, and inflammation.
Wuhan, HubeiAges 18–70 - NCT07347574Recruiting
Early Alzheimer's detection study in Hong Kong communities
This study aims to find early signs of Alzheimer's in the community through blood tests and assessments. It's for people who can think clearly and agree to participate without major health issues.
Hong KongAges 60–75 - NCT07349550Recruiting
Cognitive function, mental health, and work
This trial explores how thinking skills (like memory and focus) relate to common mental health challenges and work life. It aims to find better ways to support people with depression or anxiety who are at risk of needing sick leave.
OsloAges 18–65 - NCT07347080RecruitingEarly Phase 1
Study of a new RNA-based drug for type 2 diabetes
This trial tests an experimental injection (CR059) for type 2 diabetes. It looks at safety and how the body handles different doses. You may qualify if you have had diabetes for 3 months to 5 years and are currently managing it with diet/exercise or certain diabetes pills.
Luoyang, HenanAges 18–65
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.